-
‘Tis the Season…
Key Points In today’s Recommendations for Industry, we discuss current seasonal illnesses and what businesses should be doing. Read more below. Yesterday, with the increased discussions regarding the Omicron variant (including its many mutations and potential to affect transmissibility and potential for evading human antibodies), TAG released a Newsletter Special Edition. Please find that here.…
-
Vaccine Mandate & Booster Updates
In today’s Recommendations for Industry, we provide updates on the vaccine mandate and boosters. Read more below. Canada’s government announced last Thursday that it has lifted the “global advisory asking Canadians to avoid non-essential travel outside the country”; however, it still discourages and advises against cruise ship travel. U.S. pharmacies and doctors are now facing…
-
Where is COVID-19 Heading Now?
In today’s Recommendations for Industry, we discuss the risk matrix and the current decline of COVID-19 coinciding with the OSHA vaccination/testing standards. Read more below. The BBC reports that a recent study has found that lateral flow tests “are very good at detecting people most likely to spread COVID-19 and positive results should be trusted.”…
-
J&J Resumption Increases Vaccine Availability, But COVID Protections Still Needed
J&J Resumption Increases Vaccine Availability, But COVID Protections Still Needed Key Points: Key Points: In today’s Recommendations for Industry, we discuss the resumption of the J&J vaccine and why vaccinations don’t eliminate the need for COVID protections. Read more below. The FDA and CDC have lifted their recommended pause for the J&J COVID-19 vaccine.…
-
Answering Employee Questions on the J&J Vaccine
Answering Employee Questions on the J&J Vaccine Key Points: In today’s Recommendations for Industry, we discuss this week’s risk matrix and how to answer your employees’ questions on the J&J vaccine. Read more below. The Johnson & Johnson vaccine’s use in the U.S. is currently paused as there is investigation for blood clots. Instead of…
-
J&J Vaccine Authorized & Rolling Out
Key Points: In today’s Recommendations for Industry, we discuss FDA’s issuance of an EUA for the J&J Janssen COVID-19 Vaccine for those 18 years of age and older. Read more below. The Johnson and Johnson’s EUA has been approved by the FDA and recommended by the CDC. Last week, we discussed the J&J vaccine. Check…
-
J&J Vaccine Review (and authorization?) Coming Today
J&J Vaccine Review (and authorization?) Coming Today Key Points: In today’s Recommendations for Industry, we discuss the J&J vaccine being reviewed for EUA by FDA today. [Read More below] The FDA is allowing for more flexible storage and transportation conditions for the Pfizer COVID-19 vaccine; undiluted frozen vials of the vaccine can be “transported and…